![]() Daiichi Sankyo Daiichi Sankyo (第一三共株式会社) is a company specializing in the research, development, and manufacture of innovative pharmaceutical products. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ![]() GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | ![]() Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. | |
Founding Date | Founding Date 2005 | Founding Date 1849 | Founding Date 1999 | Founding Date 2000 | Founding Date 1876 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Braine L'alleud, BE Sao Paulo, BR Toronto, CA Shanghai, CN see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more |
Employees | Employees 18,726 | Employees 81,0008% decrease | Employees 94,300 | Employees 68,629 | Employees 47,0009% increase |
Valuation ($) | Valuation ($) 61.7 b | Valuation ($) 163.9 b | Valuation ($) 2.7 b | Valuation ($) 862.5 m | Valuation ($) 903.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥1.9t (FY, 2024) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) |
Cost of goods | Cost of goods ¥415.8b (FY, 2024) | Cost of goods $16.1b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods £5.6b (FY, 2025) | Cost of goods $11.1b (FY, 2025) |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit $46.5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit £28.5b (FY, 2025) | Gross profit $54.1b (FY, 2025) |
Net income | Net income ¥295.8b (FY, 2024) | Net income $7.8b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income £6.3b (FY, 2025) | Net income $20.6b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries 130 (FY, 2021) | Countries 92 (FY, 2021) | Countries 120 (FY, 2021) |
Phase I Trials Products | Phase I Trials Products 16 (FY, 2018) | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products 27 (FY, 2019) |
Phase II Trials Products | Phase II Trials Products 7 (FY, 2018) | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products 8 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products 7 (FY, 2018) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products 10 (FY, 2021) |

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View company